Trademarks and Copyright© The images and information contained
in the Site are, to the fullest extent possible, copyrighted and otherwise
proprietary. It is the policy of Taro to enforce its intellectual property
rights to the fullest extent of the law, including (where applicable) seeking
criminal sanctions.
| Date | Title |
12/27/2004
|
Taro Receives Approval for Hydrocortisone Butyrate Ointment, 0.1% ANDA
|
12/23/04
|
Taro to Supply Generic Elocon® Cream to Clay Park in U.S.
|
12/16/2004
|
Taro USA Receives Approval for Halobetasol Propionate Ointment, 0.05% ANDA; Company Also Receives Tentative Approval for Gabapentin Oral Solution, 250 mg/5 mL ANDA
|
12/6/04
|
Taro USA Receives Tentative Approval for Mometasone Furoate Topical Suspension USP, 0.1% (Lotion) ANDA
|
12/3/2004
|
Taro USA Receives Approval for Mometasone Furoate Ointment ANDA; Company Also Receives Tentative Approval for Mometasone Furoate Cream ANDA
|
11/22/2004
|
Taro Reports "A+" Bond Rating in Israel
|
10/28/2004
|
Taro Reports Third Quarter and Nine Month 2004 Results
|
10/26/2004
|
Taro to Report 3rd Quarter 2004 Results and Conduct Call on October 28, 2004
|
10/13/2004
|
Taro Announces Approvals of ANDAs for Betamethasone Dipropionate Ointment (Augmented) and Ciprofloxacin Tablets
|
10/1/2004
|
Taro Pharmaceutical Industries Reports Retirement of Aaron Levitt as President of the Company
|
8/20/2004
|
Taro Receives FDA Approval for Loratadine Syrup, 5 Mg / 5 mL ANDA
|
7/30/2004
|
Taro Receives FDA approval for Alclometasone Dipropionate Ointment USP, 0.05% ANDA
|
7/29/2004
|
Taro Receives Final Approval for Fluconazole Tablets ANDA
|
7/29/2004
|
Taro Receives FDA Approval for Clotrimazole and Betamethasone Dipropionate Lotion ANDA
|
7/29/2004
|
Taro Reports 2nd Quarter & Six-Month 2004 Results and Provides Update on Proprietary Drug Pipeline
|
7/27/2004
|
Taro to Report 2nd Quarter 2004 Results and Conduct Conference Call on July 29, 2004
|
6/1/2004
|
Taro Receives FDA Approval for Ammonium Lactate Lotion, 12% ANDA
|
4/29/2004
|
Taro Reports 1st Quarter 2004 Results
|
4/28/2004
|
Taro to Report 1st quarter 2004 Results
|
4/7/2004
|
Taro Receives Approval for Terconazole Vaginal Cream, 0.8% ANDA
|
3/8/2004
|
Taro Receives Approval for Phenytoin Oral suspension USP ANDA
|
2/17/2004
|
Taro Reports Record 2003 Results
|
2/13/2004
|
Taro to Report 4th Quarter and Full Year 2003 Results
|
1/8/2004
|
Taro Expands U.S. Distribution Capacity with Purchase of New Jersey Facility
|
1/8/2004
|
Taro Receives Approval for Children's ElixSuretm IB(Ibuprofen) Oral suspension NDA
|